[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342066-105":59,"doc-detail-342066-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploring-the-impact-of-the-catenin-mutations-in-hepatocellular-carcinoma-an-in-depth-review","Exploring the Impact of the β-Catenin Mutations in Hepatocellular Carcinoma - An In-Depth Review","","Liver cancer, primarily hepatocellular carcinoma (HCC), remains a major global health challenge with substantial clinical, economic, and psychological consequences, while incidence continues to rise due to hepatitis B and C infections, nonalcoholic steatohepatitis, and environmental influences. Dysregulated Wnt/β-Catenin signaling emerges as a therapeutic target, driven by CTNNB1 mutations at key β-catenin phosphorylation and armadillo repeat residues that block degradation and amplify oncogenic activity. Additional genetic “hits” cooperate with β-catenin activation to drive tumor initiation and progression. This review analyzes β-catenin signaling in HCC, linking cooperative mutations with tumor microenvironment interactions and outlining future research priorities and potential personalized therapeutic strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-the-impact-of-the-catenin-mutations-in-hepatocellular-carcinoma-an-in-depth-review/342066/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-the-impact-of-the-catenin-mutations-in-hepatocellular-carcinoma-an-in-depth-review/342066.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which pathway is emphasized as a therapeutic target in hepatocellular carcinoma?","Question",{"text":112,"@type":113},"The review highlights the Wnt/β-Catenin signaling pathway as frequently dysregulated in HCC and a promising therapeutic target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do CTNNB1 mutations affect β-catenin behavior in HCC?",{"text":117,"@type":113},"CTNNB1 mutations at critical phosphorylation sites and armadillo repeat domains impede β-catenin degradation, increasing its oncogenic potential.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is β-catenin activation alone insufficient for hepatocarcinogenesis?",{"text":121,"@type":113},"β-catenin activation requires additional cooperative genetic “hits” to enable tumor initiation and drive progression, including alterations in genes such as Ras, c-Met, NRF2, and LKB1.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342066,1790493793,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","| Exploring the Impact of the β-Catenin Mutations in Hepatocellular Carcinoma: An In-Depth Review | Cancer Control Volume 31: 1–20\u003Cbr>© The Author(s) 2024\u003Cbr>Article reuse guidelines:\u003Cbr>[sagepub.com/journals-permissions](sagepub.com/journals-permissions)\u003Cbr>[DOI: 10.1177/10732748241293680](DOI: 10.1177/10732748241293680)[ ](DOI: 10.1177/10732748241293680)[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)\u003Cbr>\u003Cbr>|\n| --- | --- |\n| Yassine Alami Idrissi, MD 1,2,* 􀀁, Mohammad Reza Rajabi, MD1,2,*, Jan H. Beumer, PHD 1,2,3, Satdarshan P. Monga, MD2,4,5,6, and Anwaar Saeed, MD 1,2\u003Cbr>Abstract\u003Cbr>Liver cancer, primarily hepatocellular carcinoma, represents a major global health issue with signiﬁcant clinical, economic, and psychological impacts. Its incidence continues to rise, driven by risk factors such as hepatitis B and C infections, nonalcoholic steatohepatitis, and various environmental inﬂuences. The Wnt/β-Catenin signaling pathway, frequently dysregulated in HCC, emerges as a promising therapeutic target. Critical genetic alterations, particularly in the CTNNB1 gene, involve mutations at key phosphorylation sites on β-catenin’s N-terminal domain (S33, S37, T41, and S45) and in armadillo repeat domains (K335I and N387 K). These mutations impede β-catenin degradation, enhancing its oncogenic potential. In addition to genetic alterations, molecular and epigenetic mechanisms, including DNA methylation, histone modiﬁcations, and noncoding RNAs, further inﬂuence β-catenin signaling and tumor progression. However, β-catenin activation alone is insufﬁcient for hepatocarcinogenesis; additional genetic “hits” are required for tumor initiation. Mutations or alterations in genes such as Ras, c-Met, NRF2, and LKB1, when combined with β-catenin activation, signiﬁcantly contribute to HCC development and progression. Understanding these cooperative mutations provides crucial insights into the disease and reveals potential therapeutic strategies. The complex interplay between genetic variations and the tumor microenvironment, coupled with novel therapeutic approaches targeting the Wnt/β-Catenin pathway, offers promise for improved treatment of HCC. Despite advances, translating preclinical ﬁndings into clinical practice remains a challenge. Future research should focus on elucidating how speciﬁc β-catenin mutations and additional genetic alterations contribute to HCC pathogenesis, leveraging genetically clengineered mouse models to explore distinct signaling impacts, and identifying downstream targets. Relevant clinical trials will be essential for advancing personalized therapies and enhancing patient outcomes. This review provides a comprehensive analysis of β-Catenin signaling in HCC, highlighting its role in pathogenesis, diagnosis, and therapeutic targeting, and identiﬁes key research directions to improve understanding and clinical outcomes.\u003Cbr>Keywords\u003Cbr>hepatocellular carcinoma, wnt/β-Catenin, signaling pathways\u003Cbr>Received July 5, 2024. Received revised September 30, 2024. Accepted for publication October 4, 2024. |  |\n| 1 Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA 2UPMC Hillman Cancer Center, Pittsburgh, PA, USA\u003Cbr>3Department of Pharmaceutical Sciences, School of Pharmacy, Pittsburgh, PA, USA\u003Cbr>4Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA\u003Cbr>5Division of Gastroenterology, Hepatology and Nutrition; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA 6Pittsburgh Liver Research Center, University of Pittsburgh and UPMC, Pittsburgh, PA, USA\u003Cbr>*Contributed equally to this work.\u003Cbr>Corresponding Author:\u003Cbr>Anwaar Saeed, MD, UPMC, Hillman Cancer Center, UPMC Cancer Pavilion, 5th Floor, 5150 Centre Avenue, Pittsburgh, PA 15232, USA. Email: [saeeda3@upmc.edu](saeeda3@upmc.edu) |  |\n\nCreative Commons Non Commercial CC BY-NC: This a","cbCaim9WqKQnE9D7","https://ap.wps.com/l/cbCaim9WqKQnE9D7","pdf",958730,"English","# Abstract\n# Introduction\n## Hepatocellular carcinoma burden and epidemiology\n## Stages of hepatocarcinogenesis and molecular drivers\n## Role of Wnt/β-Catenin signaling in tumor growth","[{\"question\":\"Which pathway is emphasized as a therapeutic target in hepatocellular carcinoma?\",\"answer\":\"The review highlights the Wnt/β-Catenin signaling pathway as frequently dysregulated in HCC and a promising therapeutic target.\"},{\"question\":\"How do CTNNB1 mutations affect β-catenin behavior in HCC?\",\"answer\":\"CTNNB1 mutations at critical phosphorylation sites and armadillo repeat domains impede β-catenin degradation, increasing its oncogenic potential.\"},{\"question\":\"Why is β-catenin activation alone insufficient for hepatocarcinogenesis?\",\"answer\":\"β-catenin activation requires additional cooperative genetic “hits” to enable tumor initiation and drive progression, including alterations in genes such as Ras, c-Met, NRF2, and LKB1.\"}]","Exploring the Impact of the β-Catenin Mutations in Hepatocellular Carcinoma - An In-Depth Review | PDF",1790044999,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b4bb4991b2bb2cbfdd3b7f19892cb78.webp",983,1272,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a082c4f184b2f40060cbf7cea427012.webp",982,1270,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8cd9a5a468d160eb94a00bddd18265f7.webp",981,1269,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9b470f61c361025c2a52bad966d0130.webp",980,1268]